Proto Labs (PRLB) drew fresh attention after reporting first quarter revenue growth of 10.4% year on year, along with EPS guidance for the upcoming quarter that came in ahead of analyst expectations.
See our latest analysis for Proto Labs.
The stock has responded positively around the earnings release, with a 1-month share price return of 10.43% and a year to date share price return of 38.97%. The 1-year total shareholder return of 93.81% points to strong recent momentum compared with a weaker 5-year total shareholder return, which is down 20.17%.
If this earnings reaction has you looking for other potential opportunities in industrial and manufacturing technologies, it could be worth scanning 35 robotics and automation stocks
With Proto Labs trading near US$71 and sitting only about 6% below the average analyst price target, the key question for you is whether recent momentum leaves upside on the table or if the stock already reflects expected future growth.
Most Popular Narrative: 0% Undervalued
The most followed Proto Labs narrative pegs fair value at about $71.67, only slightly above the last close of $71.36. This keeps expectations tight around the current price.
Ongoing investments in sales enablement, marketing, and optimization of fulfillment channels are improving customer experience and wallet share, evidenced by higher revenue per customer (+11% y/y) and increased cross-platform adoption (+44% y/y), which points to future top-line growth and improved earnings quality.
Want to see what kind of revenue path and margin profile sit behind that fair value line, and how rich a future earnings multiple this narrative assumes?
Result: Fair Value of $71.67 (ABOUT RIGHT)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this narrative still hinges on Proto Labs managing customer concentration in Aerospace & Defense and avoiding prolonged weakness in European manufacturing, both of which could pressure growth and margins.
Find out about the key risks to this Proto Labs narrative.
Another Angle On Value
The narrative fair value of about $71.67 lines up closely with the current $71.36 share price, but the SWS DCF model tells a different story. On that approach, Proto Labs is valued at $41.59 per share, which makes the current price look expensive and raises the question of which set of assumptions is more realistic.
Look into how the SWS DCF model arrives at its fair value.
Next Steps
Mixed messages on value and risk so far? Take a closer look at the numbers, weigh the upside against the concerns, and check the 2 key rewards and 1 important warning sign
Looking for more investment ideas?
If Proto Labs has sharpened your focus, do not stop here. Broaden your watchlist with stocks that fit clear, high quality themes using the Simply Wall Street Screener.
- Target resilient income by checking out companies with robust payouts and yields among the 10 dividend fortresses.
- Spot potential bargains by scanning the 49 high quality undervalued stocks that pair solid fundamentals with appealing pricing.
- Strengthen your core holdings by reviewing the solid balance sheet and fundamentals stocks screener (46 results) for companies that prioritize financial stability.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com